Endometrial Hyperplasia Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Endometrial Hyperplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 2

Uterine Preservation Via Lifestyle Transformation

Endometrial HyperplasiaGrade 1 Endometrial Cancer
Washington University School of Medicine96 enrolled3 locationsNCT05903131
Recruiting

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Ovarian CancerCervical CancerEndometrial Cancer+3 more
Mayo Clinic3,110 enrolled24 locationsNCT05051722
Recruiting

The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons

Ovarian CancerEndometrial CancerEndometrial Cancer Precursors+1 more
University of Alabama at Birmingham1,500 enrolled1 locationNCT03538665
Recruiting
Phase 2Phase 3

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance
Xiaojun Chen80 enrolled2 locationsNCT05316935
Recruiting
Phase 2Phase 3

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

ObesityEndometrial NeoplasmsAtypical Endometrial Hyperplasia+1 more
Xiaojun Chen29 enrolled2 locationsNCT06379113
Recruiting

Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment

Fertility PreservationEndometrial AdenocarcinomaEndometrial Hyperplasia+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS100 enrolled1 locationNCT07077876
Recruiting

Cohort Study of Intrauterine Diseases

Endometrial CancerEndometrial HyperplasiaEndometrial Polyps
Wenwen Wang2,000 enrolled1 locationNCT07048327
Recruiting

Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer

Atypical Endometrial HyperplasiaEndometrial Carcinoma Stage I
Peking University People's Hospital244 enrolled1 locationNCT05647109
Recruiting
Phase 2

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
Peking University People's Hospital38 enrolled1 locationNCT06102863
Recruiting
Not Applicable

Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.

Endometrial CancerPost-Menopausal BleedingEndometrial Hyperplasia
Imperial College Healthcare NHS Trust92 enrolled1 locationNCT06501846
Recruiting
Phase 2

Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Atypical Endometrial HyperplasiaEndometrial Carcinoma Stage I
Peking University People's Hospital82 enrolled1 locationNCT05675787
Recruiting
Not Applicable

Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women

Endometrial Cancer Stage IEndometrial Hyperplasia
Women's Hospital School Of Medicine Zhejiang University75 enrolled1 locationNCT06417736
Recruiting
Not Applicable

Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia

Endometrial CancerGynecologic CancerEndometrial Hyperplasia
Vancouver Coastal Health Research Institute30 enrolled1 locationNCT04362046
Recruiting
Phase 2Phase 3

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Endometrial CancerAtypical Endometrial Hyperplasia
West China Second University Hospital224 enrolled1 locationNCT03463252